活性药物Ingredients Market Size, Share & Trends Analysis Report By Type Of Synthesis (Biotech, Synthetic), By Type Of Manufacturer (Captive, Merchant), By Type, By Application, By Region, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Regional scope
1.1.2 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased database:
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 Research Assumptions
1.8 Key KoL Responses
1.9 Market share calculations
1.10 List of Secondary Sources
1.11 List of Abbreviations
1.12 Objectives
1.12.1 Objective 1
1.12.2 Objective 2
1.12.3 Objective 3
1.12.4 Objective 4
Chapter 2 Executive Summary
2.1 Segment Outlook
2.2 Competitive Outlook
2.3 Market Outlook
Chapter 3 API Market Variables, Trends, and Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Penetration and Growth Prospect Mapping
3.3 User Perspective Analysis
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Growing geriatric population
3.4.1.2 Rising prevalence of target diseases such as hospital-acquired infections, genetic, cardiovascular, and neurological diseases
3.4.1.3 Increasing preference for targeted therapy approach in cancer treatment
3.4.1.4 Increasing preference for outsourcing APIs
3.4.2 Market Restraint Analysis
3.4.2.1 High capital investments and production cost
3.4.2.2 Stringent Safety and handling regulations regarding APIs
3.5 Market Analysis Tools
3.5.1 Industry Analysis: Porter’s
3.5.2 PESTLE Analysis
3.5.3 Regulatory Scenario
Chapter 4 API Market: Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.1.1 Ansoff matrix
4.1.2 Heat map analysis
4.2 Company Categorization
4.2.1 Innovators
4.2.2 Market Leaders
4.3 Vendor Landscape
4.3.1 List of key distributors and channel partners
4.3.2 Key customers
4.3.3 Key company market share analysis, 2021
4.4 Public Companies
4.4.1 Company market position analysis
4.4.2 Company market position analysis
4.4.3 Competitive Dashboard Analysis
4.4.3.1 Market Differentiators
4.5 Private Companies
4.5.1 List of key emerging companies
4.6 Major Deals and Strategic Alliances Analysis
4.6.1 Joint Ventures
4.6.2 Acquisitions
4.6.3 Licensing and Partnerships
4.6.4 Technological Collaborations
Chapter 5 API Molecules Outlook
5.1 Global Sales of API Molecules, USD Million, 2018 - 2020
5.2 Companies with the leading market position for API molecules
5.2.1 Amoxicillin
5.2.2 Azithromycin
5.2.3 Bleomycin
5.2.4 Caspofungin
5.2.5 Clarithromycin
5.2.6 Clavulanic acid
5.2.7 Clindamycin
5.2.8 Compactin (Mevastatin)
5.2.9 Cyclosporin
5.2.10 Dactinomycin
5.2.11 Daptomycin
5.2.12 Demeclocycline
5.2.13 Doxycycline
5.2.14 Erythromycin
5.2.15 Ivermectin (Avermectin)
5.2.16 Lovastatin
5.2.17 Micafungin
5.2.18 Minocycline
5.2.19 Mitomycin
5.2.20 Mycophenolic acid
5.2.21 Pneumocandin B0
5.2.22 Polymyxin
5.2.23 Pravastatin
5.2.24 Rapamycin (Sirolimus)
5.2.25 Simvastatin
5.2.26 Steroids
5.2.27 Tacrolimus
5.2.28 Tetracycline
5.2.29 Tigecycline
5.2.30 Tobramycin
5.2.31 Vancomycin
5.3 Comparative price analysis of the above-mentioned molecules
Chapter 6 API Market: Segment Analysis, by Type of Synthesis, 2018 - 2030 (USD Billion)
6.1 Definition and Scope
6.2 Type of Synthesis Market Share Analysis, 2021 & 2030
6.3 Segment Dashboard
6.4 Global API Market, by Type of Synthesis, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.5.1 Biotech API
6.5.1.1 Biotech API market, 2018 - 2030 (USD Billion)
6.5.1.2 Biotech API market, By Type, 2018 - 2030 (USD Billion)
6.5.1.3 Generic APIs
6.5.1.3.1 Generic APIs market, 2018 - 2030 (USD Billion)
6.5.1.4 Innovative APIs
6.5.1.4.1 Innovative APIs market, 2018 - 2030 (USD Billion)
6.5.1.5 Biotech APIs Market, By Product (Revenue, USD Billion, 2018 - 2030)
6.5.1.6 Monoclonal Antibodies
6.5.1.6.1 Monoclonal Antibodies market, 2018 - 2030 (USD Billion)
6.5.1.7 Hormones
6.5.1.7.1 Hormones market, 2018 - 2030 (USD Billion)
6.5.1.8 Cytokines
6.5.1.8.1 Cytokines market, 2018 - 2030 (USD Billion)
6.5.1.9 Recombinant Proteins
6.5.1.9.1 Recombinant Proteins market, 2018 - 2030 (USD Billion)
6.5.1.10 Therapeutic Enzymes
6.5.1.10.1 Therapeutic enzymes market, 2018 - 2030 (USD Billion)
6.5.1.11 Vaccines
6.5.1.11.1 Vaccines market, 2018 - 2030 (USD Billion)
6.5.1.12 Blood Factors
6.5.1.12.1 Blood factors market, 2018 - 2030 (USD Billion)
6.5.2 Synthetic API
6.5.2.1 Synthetic API market, 2018 - 2030 (USD Billion)
6.5.2.2 Synthetic APIs Market, By Type (Revenue, USD Billion, 2018 - 2030)
6.5.2.3 Generic APIs
6.5.2.3.1 Generic APIs market, 2018 - 2030 (USD Billion)
6.5.2.4 Innovative APIs
6.5.2.4.1 Innovative APIs market, 2018 - 2030 (USD Billion)
Chapter 7 API Market: Segment Analysis, by Type of Manufacturer, 2018 - 2030 (USD Billion)
7.1 Definition and Scope
7.2 Type of Manufacturer Market Share Analysis, 2021 & 2030
7.3 Segment Dashboard
7.4 Global API Market, by Type of Manufacturers, 2018 to 2030
7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
7.5.1 Captive API
7.5.1.1 Captive API market, 2018 - 2030 (USD Billion)
7.5.2 Merchant API
7.5.2.1 Captive API market, 2018 - 2030 (USD Billion)
7.5.2.2 Merchant APIs Market, By Type (Revenue, USD Billion, 2018 - 2030)
7.5.2.3 Generic APIs
7.5.2.3.1 Generic APIs market, 2018 - 2030 (USD Billion)
7.5.2.4 Innovative APIs
7.5.2.4.1 Innovative APIs market, 2018 - 2030 (USD Billion)
7.5.2.5 Merchant APIs Market, By Type of Synthesis (Revenue, USD Billion, 2018 - 2030)
7.5.2.6 Biotech
7.5.2.6.1 Biotech market, 2018 - 2030 (USD Billion)
7.5.2.7 Synthetic
7.5.2.7.1 Synthetic market, 2018 - 2030 (USD Billion)
Chapter 8 API Market: Segment Analysis, by Type, 2018 - 2030 (USD Billion)
8.1 Definition and Scope
8.2 Type Market Share Analysis, 2020 & 2030
8.3 Segment Dashboard
8.4 Global API Market, by Type, 2018 to 2030
8.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
8.5.1 Generic APIS
8.5.1.1 Generic APIs market, 2018 - 2030 (USD Billion)
8.5.2 Innovative APIs
8.5.2.1 Innovative APIS market, 2018 - 2030 (USD Billion)
Chapter 9 API Market: Segment Analysis, by Application, 2018 - 2030 (USD Billion)
9.1 Definition and Scope
9.2 Application Market Share Analysis, 2021 & 2030
9.3 Segment Dashboard
9.4 Global API Market, by Application, 2018 to 2030
9.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
9.5.1 Cardiovascular Diseases
9.5.1.1 Cardiovascular diseases market, 2018 - 2030 (USD Billion)
9.5.2 Oncology
9.5.2.1 Oncology market, 2018 - 2030 (USD Billion)
9.5.3 CNS and Neurology
9.5.3.1 CNS and neurology market, 2018 - 2030 (USD Billion)
9.5.4 Orthopedics
9.5.4.1 Orthopedics market, 2018 - 2030 (USD Billion)
9.5.5 Endocrinology
9.5.5.1 Endocrinology market, 2018 - 2030 (USD Billion)
9.5.6 Pulmonology
9.5.6.1 Pulmonology market, 2018 - 2030 (USD Billion)
9.5.7 Gastroenterology
9.5.7.1 Gastroenterology market, 2018 - 2030 (USD Billion)
9.5.8 Nephrology
9.5.8.1 Nephrology market, 2018 - 2030 (USD Billion)
9.5.9 Ophthalmology
9.5.9.1 Ophthalmology market, 2018 - 2030 (USD Billion)
9.5.10 Others
9.5.10.1 Others market, 2018 - 2030 (USD Billion)
Chapter 8 API Market: Segment Analysis, by Type of Drug, 2018 - 2030 (USD Billion)
10.1 Definition and Scope
10.2 Type of Drug Market Share Analysis, 2020 & 2030
10.3 Segment Dashboard
10.4 Global API Market, by Type of Drug, 2018 to 2030
10.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
10.5.1 Prescription
10.5.1.1 Prescription market, 2018 - 2030 (USD Billion)
10.5.2 OTC
10.5.2.1 OTC market, 2018 - 2030 (USD Billion)
Chapter 10 API Market: Regional Market Analysis, 2018 - 2030 (USD Billion)
11.1 Definition & Scope
11.2 Regional Market Share Analysis, 2021 & 2030
11.3 Regional Market Dashboard
11.4 Regional Market Snapshot
11.5 SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
11.5.1 North America
11.5.2 Europe
11.5.3 Asia Pacific
11.5.4 Latin America
11.5.5 MEA
11.6 Market Size, & Forecasts, Trend Analysis, 2018 to 2030
11.7 North America
11.7.1 North America Market estimates and forecast, 2018 - 2030 (USD Billion)
11.7.2 U.S.
11.7.2.1 U.S. API market, 2018 - 2030 (USD Billion)
11.7.3 Canada
11.7.3.1 Canada API market, 2018 - 2030 (USD Billion)
11.8 Europe
11.8.1 Europe API market, 2018 - 2030 (USD Billion)
11.8.2 U.K.
11.8.2.1 U.K. API market, 2018 - 2030 (USD Billion)
11.8.3 Germany
11.8.3.1 Germany API market, 2018 - 2030 (USD Billion)
11.8.4 Spain
11.8.4.1 Spain API market, 2018 - 2030 (USD Billion)
11.8.5 France
11.8.5.1 France API market, 2018 - 2030 (USD Billion)
11.8.6 Italy
11.8.6.1 Italy API market, 2018 - 2030 (USD Billion)
11.8.7 Russia
11.8.7.1 Russia API market, 2018 - 2030 (USD Billion)
11.8.8 Hungary
11.8.8.1 Hungary API market, 2018 - 2030 (USD Billion)
11.9 Asia Pacific
11.9.1 Asia Pacific API market, 2018 - 2030 (USD Billion)
11.9.2 Japan
11.9.2.1 Japan API market, 2018 - 2030 (USD Billion)
11.9.3 China
11.9.3.1 China API market, 2018 - 2030 (USD Billion)
11.9.4 India
11.9.4.1 India API market, 2018 - 2030 (USD Billion)
11.9.5 South Korea
11.9.5.1 South Korea API market, 2018 - 2030 (USD Billion)
11.9.6 Australia
11.9.6.1 Australia API market, 2018 - 2030 (USD Billion)
11.10 Latin America
11.10.1 Latin America API Market, 2018 - 2030 (USD Billion)
11.10.2 Brazil
11.10.2.1 Brazil API market, 2018 - 2030 (USD Billion)
11.10.3 Mexico
11.10.3.1 Mexico API market, 2018 - 2030 (USD Billion)
11.10.4 Argentina
11.10.4.1 Argentina API market, 2018 - 2030 (USD Billion)
11.11 MEA
11.11.1 MEA API market, 2018 - 2030 (USD Billion)
11.11.2 South Africa
11.11.2.1 South Africa API market, 2018 - 2030 (USD Billion)
11.11.3 Saudi Arabia
11.11.3.1 Saudi Arabia API market, 2018 - 2030 (USD Billion)
11.11.4 UAE
11.11.4.1 UAE API market, 2018 - 2030 (USD Billion)
Chapter 12 Company Profiles
12.1 AbbVie, Inc.
12.1.1 Company overview
12.1.2 Financial performance
12.1.3 Product benchmarking
12.1.4 Strategic initiatives
12.2 Boehringer Ingelheim International GmbH
12.2.1 Company overview
12.2.2 Financial performance
12.2.3 Product benchmarking
12.2.4 Strategic initiatives
12.3 Bristol-Myers Squibb Company
12.3.1 Company overview
12.3.2 Financial performance
12.3.3 Product benchmarking
12.3.4 Strategic initiatives
12.4 Cipla, Inc.
12.4.1 Company overview
12.4.2 Financial performance
12.4.3 Product benchmarking
12.4.4 Strategic initiatives
12.5 Merck & Co., Inc.
12.5.1 Company overview
12.5.2 Financial performance
12.5.3 Product benchmarking
12.5.4 Strategic initiatives
12.6 Albemarle Corporation
12.6.1 Company overview
12.6.2 Financial performance
12.6.3 Product benchmarking
12.7 Aurobindo Pharma
12.7.1 Company overview
12.7.2 Financial performance
12.7.3 Product benchmarking
12.7.4 Strategic initiatives
12.8 Viatris Inc. (Mylan N.V.)
12.8.1 Company overview
12.8.2 Financial performance
12.8.3 Product benchmarking
12.8.4 Strategic initiatives
12.9 Teva Pharmaceutical Industries Ltd.
12.9.1 Company overview
12.9.2 Financial performance
12.9.3 Product benchmarking
12.9.4 Strategic initiatives
12.10 Sun Pharmaceutical Industries Ltd.
12.10.1 Company overview
12.10.2 Financial performance
12.10.3 Product benchmarking
12.10.4 Strategic initiatives
12.11 Dr. Reddy’s Laboratories Ltd.
12.12.1 Company overview
12.12.2 Financial performance
12.12.3 Product benchmarking
12.12.4 Strategic initiatives

List of Tables

TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Regulatory Framework
TABLE 4 Global Active Pharmaceutical Ingredients Market, By Region, 2018 - 2030 (USD Billion)
TABLE 5 Global Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 6 Global Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 7 Global Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 8 Global Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 9 North America Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
TABLE 10 North America Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 11 North America Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 12 North America Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 13 North America Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 14 U.S. Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 15 U.S. Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 16 U.S. Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 17 U.S. Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 18 Canada Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 19 Canada Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 20 Canada Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 21 Canada Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 22 Europe Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
TABLE 23 Europe Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 24 Europe Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 25 Europe Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 26 Europe Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 27 U.K. Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 28 U.K. Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 29 U.K. Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 30 U.K. Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 31 Germany Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
表32德国活性药物成分Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 33 Germany America Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 34 Germany America Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 35 France Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 36 France Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 37 France Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 38 France Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 39 Spain Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 40 Spain Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 41 Spain Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 42 Spain Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 43 Italy Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 44 Italy Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 45 Italy Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 46 Italy Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 47 Russia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 48 Russia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 49 Russia Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 50 Russia Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 51 Asia Pacific Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
TABLE 52 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 53 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 54 Asia Pacific Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
表亚太活性药物是55ients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 56 China Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 57 China Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 58 China Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 59 China Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 60 Japan Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 61 Japan Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 62 Japan Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 63 Japan Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 64 India Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 65 India Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 66 India Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 67 India Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 68 South Korea Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 69 South Korea Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 70 South Korea Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 71 South Korea Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 72 Australia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 73 Australia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 74 Australia Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 75 Australia Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 76 Latin America Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
TABLE 77 Latin America Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 78 Latin America Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 79 Latin America Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 80 Latin America Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 81 Brazil Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 82 Brazil Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 83 Brazil Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 84 Brazil Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 85 Mexico Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 86 Mexico Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 87 Mexico Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 88 Mexico Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 89 Argentina Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 90 Argentina Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 91 Argentina Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 92 Argentina Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
表93年3月活性药物成分ket, By Country, 2018 - 2030 (USD Billion)
TABLE 94 MEA Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 95 MEA Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 96 MEA Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 97 MEA Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 98 South Africa Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
表99年南非活性药物是ients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 100 South Africa Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 101 South Africa Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 102 UAE Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
表103年阿联酋活性药物成分rket, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 104 UAE Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 105 UAE Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 106 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 107 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 108 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 109 Saudi Arabia Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)

List of Figures

FIG. 1 API market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value-chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 API market, segment outlook
FIG. 10 API market, competitive outlook
FIG. 11 API market outlook (2021)
FIG. 12 Penetration & growth prospect mapping
FIG. 13 User perspective analysis
FIG. 14 Market driver relevance analysis (Current & future impact)
FIG. 15 Global percentage of the population, by age group, 2050 and 2000
FIG. 16 Market restraint relevance analysis (Current & future impact)
FIG. 17 Porter’s five forces analysis
FIG. 18 PESTLE analysis
FIG. 19 Ansoff Matrix
FIG. 20 Heat map analysis
FIG. 21 Company market position analysis
FIG. 22 Company market position analysis
FIG. 23 Market differentiators
FIG. 24 Strategy mapping
FIG. 25 API market: Type of synthesis movement analysis
FIG. 26 Segment dashboard
FIG. 27 API market type of synthesis outlook: Key takeaways
FIG. 28 Biotech API market, 2018 - 2030 (USD Billion)
FIG. 29 Biotech APIs Market, By Product (Revenue, USD Billion, 2018 - 2030)
FIG. 30 Monoclonal Antibodies market, 2018 - 2030 (USD Billion)
FIG. 31 Hormones market, 2018 - 2030 (USD Billion)
FIG. 32 Cytokines market, 2018 - 2030 (USD Billion)
FIG. 33 Recombinant Proteins market, 2018 - 2030 (USD Billion)
FIG. 34 Therapeutic Enzymes market, 2018 - 2030 (USD Billion)
FIG. 35 Vaccines market, 2018 - 2030 (USD Billion)
FIG. 36 Blood Factors market, 2018 - 2030 (USD Billion)
FIG. 37 Synthetic API market, 2018 - 2030 (USD Billion)
FIG. 38 API market: Type of manufacturers movement analysis
FIG. 39 Segment dashboard
FIG. 40 API market type of manufacturers outlook: Key takeaways
FIG. 41 Captive API market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 42 Merchant API market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 43 API market: Type movement analysis
FIG. 44 Segment dashboard
FIG. 45 API market type outlook: Key takeaways
FIG. 46 Generic APIs market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 47 Innovative APIs market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 48 API market: Type of Drug movement analysis
FIG. 49 Segment dashboard
FIG. 50 API market type of drug outlook: Key takeaways
FIG. 51 Prescription market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 52 OTC market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 53 API market: Application movement analysis
FIG. 54 Segment dashboard
FIG. 55 API market application outlook: Key takeaways
FIG. 56 Cardiovascular diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 57 Oncology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 58 CNS & neurology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 59 Orthopedics market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 60 Endocrinology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 61 Pulmonology market estimates and forecast, 2018 - 2030 (USD Billion)
图62胃肠病学市场预期和前cast, 2018 - 2030 (USD Billion)
FIG. 63 Nephrology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 64 Ophthalmology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 65 Others market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 66 Regional outlook, 2021 & 2030
FIG. 67 Regional market dashboard
FIG. 68 Regional market place: Key takeaways
FIG. 69 North America, SWOT Analysis
FIG. 70 Europe, SWOT Analysis
FIG. 71 Asia Pacific, SWOT Analysis
FIG. 72 Latin America, SWOT Analysis
FIG. 73 MEA, SWOT Analysis
FIG. 74 North America
FIG. 75 North America market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 76 U.S.
FIG. 77 U.S. market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 78 Canada
FIG. 79 Canada market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 80 Europe
FIG. 81 Europe market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 82 U.K.
FIG. 83 U.K. market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 84 Germany
FIG. 85 Germany market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 86 Spain
FIG. 87 Spain market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 88 France
FIG. 89 France market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 90 Italy
FIG. 91 Italy market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 92 Russia
FIG. 93 Russia market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 94 Hungary
FIG. 95 Hungary market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 96 Asia Pacific
FIG. 97 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 98 Japan
FIG. 99 Japan market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 100 China
FIG. 101 China market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 102 India
FIG. 103 India market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 104 South Korea
FIG. 105 South Korea market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 106 Australia
FIG. 107 Australia market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 108 Latin America
FIG. 109 Latin America market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 110 Brazil
FIG. 111 Brazil market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 112 Mexico
FIG. 113 Mexico market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 114 Argentina
FIG. 115 Argentina market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 116 MEA
FIG. 117 MEA market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 118 South Africa
FIG. 119 South Africa market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 120 Saudi Arabia
FIG. 121 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 122 UAE
FIG. 123 UAE market estimates and forecast, 2018 - 2030 (USD Billion)